Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934

NCT02064426 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia
Renal Insufficiency, Chronic

Interventions

DRUG: Molidustat (BAY85-3934)
BIOLOGICAL: Epoetin alfa/beta

Sponsor

Bayer